Skip to main content

and
  1. No Access

    Article

    A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease

    Short-acting β2-agonist bronchodilators are the most common medications used in treating chronic obstructive pulmonary disease (COPD). Genetic variants determining bronchodilator responsiveness (BDR) in COPD have...

    M Hardin, M H Cho, M-L McDonald, E Wan, D A Lomas in The Pharmacogenomics Journal (2016)